Ratnikova L I
Zh Mikrobiol Epidemiol Immunobiol. 1991 Sep(9):56-8.
Bemitil, administered orally in a dose of 0.25-0.5 g a day for 5-7 days at the acute period of the relapse of erysipelas as an immunostimulant, enhanced the effectiveness of the basic therapy including antibiotics, anti-inflammatory and antiallergic drugs, vitamins, plasma-substituting fluids and saline solutions, as well as ultraviolet irradiation of the focus of lesion. Bemitil therapy was associated with an increase in the number of T-lymphocytes, normalization of the balance between the peripheral lymphocyte preparations, an increase of blood serum levels of IgA and IgM.
在丹毒复发急性期，作为免疫刺激剂的贝米替尔，以每日0.25 - 0.5克的剂量口服5 - 7天，可提高包括抗生素、抗炎和抗过敏药物、维生素、血浆代用品和盐溶液在内的基础治疗的效果，以及病灶部位的紫外线照射效果。贝米替尔治疗与T淋巴细胞数量增加、外周淋巴细胞制剂平衡正常化、血清IgA和IgM水平升高有关。
